Most symptoms are gastrointestinal and typically occur during the first few weeks of treatment or following a dosage increase
GLP-1s impact digestion, vagal tone, appetite signaling, bowel motility, and cardiometabolic markers, and they interact with stress physiology and immune activation in ways that can either support or destabilize clients already navigating complex chronic conditions
Although these treatments may be effective at treating the symptoms of depression by increasing the availability of monoamines at the receptor site, they may not be successfully treating the underlying cause of this debilitating condition
Compare Reputable DSIP Suppliers Before choosing a DSIP research source, compare the available product formats, current pricing, purity information, testing documentation, and batch-specific certificates of analysis